Semasize 0.25mg/0.5mg Pre-filled Pen

Semasize 0.25mg/0.5mg Pre-filled Pen

Semasize 0.25mg/0.5mg Pre-filled Pen contains Semaglutide Solution for Injection 2mg/1.5ml (1.34mg/ml), a GLP-1 receptor agonist used as part of a comprehensive weight management program for adults with obesity or excess body weight associated with weight-related health conditions. This is a starter titration pen that can be dialled to deliver either 4 doses of 0.25mg plus 2 doses of 0.5mg, or 4 doses of 0.5mg, with the dose marked directly inside the pen window. It helps regulate appetite, reduce food intake, and support sustainable weight loss when combined with a healthy diet and regular physical activity.

Key Features

• Contains Semaglutide 2mg/1.5ml: A GLP-1 receptor agonist for chronic weight management.
• Dual-Dose Titration Pen: Dial to 0.25mg or 0.5mg for a full dose, ideal for treatment initiation.
• Once-Weekly Administration: Convenient dosing schedule.
• Ready-to-Use: No separate reusable injector device required.
• Manufactured by Alkem Laboratories Ltd.

Key Ingredient

• Semaglutide 2mg/1.5ml (1.34mg/ml): Helps regulate appetite and support long-term weight management.

How to Use

• Use exactly as prescribed by your healthcare professional.
• Dial to 0.25mg or 0.5mg on the pen window for a full dose, as instructed by your doctor.
• Administer as a subcutaneous injection once weekly, into the abdomen, thigh, or upper arm.
• Use on the same day each week, at any time of day.
• Follow the recommended diet and exercise program during treatment.

Precautions

• Use only under medical supervision.
• Inform your doctor about any history of pancreatitis, thyroid disorders, kidney disease, or gastrointestinal conditions.
• Do not share injection devices with others.
• Store as directed on the product packaging (refrigerate 2-8 degrees C; do not freeze).
• Keep out of reach of children.

Warning

• May cause nausea, vomiting, diarrhea, constipation, abdominal pain, or decreased appetite.
• Seek immediate medical attention if severe abdominal pain or allergic reactions occur.
• Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.
• Do not exceed the prescribed dosage.

Legal Disclaimer: This product is a prescription medication intended for chronic weight management in eligible adults, to be sold only on the prescription of an Endocrinologist or Internal Medicine specialist. Use only under the supervision of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.